William Kerns

2.4k total citations · 1 hit paper
44 papers, 1.8k citations indexed

About

William Kerns is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, William Kerns has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in William Kerns's work include Lipoproteins and Cardiovascular Health (7 papers), Carcinogens and Genotoxicity Assessment (6 papers) and Adenosine and Purinergic Signaling (6 papers). William Kerns is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Carcinogens and Genotoxicity Assessment (6 papers) and Adenosine and Purinergic Signaling (6 papers). William Kerns collaborates with scholars based in United States, United Kingdom and Israel. William Kerns's co-authors include Kenneth L. Pavkov, James A. Swenberg, Edward J. Gralla, Pnina Fishman, Michael H. Silverman, Peter J. Bugelski, Thomas B. Starr, Xuezhi Jiang, Kevin T. Morgan and Shira Cohen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

William Kerns

41 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure.

1983 491 citations William Kerns, Kenneth L. Pavkov et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Kerns United States	20	553	486	463	167	165	44	1.8k
Sunderman Fw United States	26	840 1.5×	285 0.6×	317 0.7×	38 0.2×	101 0.6×	91	2.0k
Choudari Kommineni United States	18	360 0.7×	180 0.4×	371 0.8×	16 0.1×	272 1.6×	36	1.9k
David W. Pyatt United States	19	356 0.6×	342 0.7×	283 0.6×	14 0.1×	115 0.7×	37	1.1k
Matthew Stoner United States	22	375 0.7×	239 0.5×	668 1.4×	27 0.2×	63 0.4×	27	1.7k
Barbara A. Olson United States	18	194 0.4×	132 0.3×	886 1.9×	48 0.3×	67 0.4×	45	1.8k
Ewa Jabłońska Poland	23	488 0.9×	284 0.6×	565 1.2×	17 0.1×	928 5.6×	158	2.6k
Zhong‐Ning Lin China	27	478 0.9×	261 0.5×	684 1.5×	23 0.1×	110 0.7×	62	1.9k
Akihiko Maekawa Japan	25	520 0.9×	359 0.7×	444 1.0×	8 0.0×	176 1.1×	112	2.0k
Hossein Mozdarani Iran	25	83 0.2×	692 1.4×	817 1.8×	43 0.3×	111 0.7×	223	2.3k
Xiaojiang Xu United States	31	115 0.2×	303 0.6×	1.2k 2.5×	95 0.6×	405 2.5×	76	2.9k

Countries citing papers authored by William Kerns

Since Specialization

Citations

This map shows the geographic impact of William Kerns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Kerns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Kerns more than expected).

Fields of papers citing papers by William Kerns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Kerns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Kerns. The network helps show where William Kerns may publish in the future.

Co-authorship network of co-authors of William Kerns

This figure shows the co-authorship network connecting the top 25 collaborators of William Kerns. A scholar is included among the top collaborators of William Kerns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Kerns. William Kerns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fishman, Pnina, Salomon M. Stemmer, Avital Bareket‐Samish, Michael H. Silverman, & William Kerns. (2023). Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects. Purinergic Signalling. 19(3). 513–522. 11 indexed citations

Stemmer, Salomon M., Ofer Benjaminov, Michael H. Silverman, et al.. (2012). CF102 for the treatment of hepatocellular carcinoma: A phase I/II, open-label, dose-escalation study.. Journal of Clinical Oncology. 30(15_suppl). e14731–e14731. 2 indexed citations

Hakura, Atsushi, Jiro Sonoda, Satoru Hosokawa, et al.. (2011). Rapid induction of colonic adenocarcinoma in mice exposed to benzo[a]pyrene and dextran sulfate sodium. Food and Chemical Toxicology. 49(11). 2997–3001. 25 indexed citations

Bar‐Yehuda, Sara, Michael H. Silverman, William Kerns, et al.. (2007). The anti-inflammatory effect of A₃adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis. Expert Opinion on Investigational Drugs. 16(10). 1601–1613. 77 indexed citations

Carey, Wayne, Steve Warrington, William Kerns, et al.. (2004). Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men. International Journal of Clinical Pharmacology and Therapeutics. 42(10). 534–542. 55 indexed citations

Kerns, William, Lester W. Schwartz, Kerry T. Blanchard, et al.. (2004). Drug-induced vascular injury—a quest for biomarkers. Toxicology and Applied Pharmacology. 203(1). 62–87. 55 indexed citations

Hakura, Atsushi, Satoshi O. Suzuki, Shigeki Sawada, et al.. (2003). Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors. Regulatory Toxicology and Pharmacology. 37(1). 20–27. 29 indexed citations

Aoki, Toyohiko, et al.. (2002). Effects of Clofibrate in the CB6F1-TgHras2 Mice.. Journal of Toxicologic Pathology. 15(2). 111–118. 1 indexed citations

Hakura, Atsushi, Jiro Sonoda, Takashi Mikami, et al.. (1999). Multiple organ mutation in the lacZ transgenic mouse (Muta™ Mouse) 6 months after oral treatment (5 days) with benzo[a]pyrene. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 426(1). 71–77. 22 indexed citations

10.

Sellers, Teresa S., et al.. (1998). Altered Hemostasis in Male Rats Following Administration of the ACAT Inhibitor SKF-99085. Toxicological Sciences. 46(1). 151–154. 2 indexed citations

11.

Berkhout, Theo A., Brian Jackson, John Yates, et al.. (1997). SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesis. Atherosclerosis. 133(2). 203–212. 19 indexed citations

12.

Jones, H. B., et al.. (1996). Characterization of Coronary Arterial Lesions in the Dog Following Administration of SK&F 95654, a Phosphodiesterase III Inhibitor. Toxicologic Pathology. 24(4). 429–435. 17 indexed citations

13.

Wier, Patrick J., et al.. (1995). Background data of reproductive and developmental toxicity studies : 3. Types and frequencies of skeletal malformations and variations in rats and rabbits : The 35th Annual Meeting of the Japanese Teratology Society. Congenital Anomalies. 35(3). 395–396. 1 indexed citations

14.

Kerns, William, et al.. (1995). Evidence of foam cell and cholesterol crystal formation in macrophages incubated with oxidized LDL by fluorescence and electron microscopy.. Journal of Histochemistry & Cytochemistry. 43(10). 1071–1078. 54 indexed citations

15.

Boor, Peter, et al.. (1995). Chemical-Induced Vasculature Injury. Toxicology and Applied Pharmacology. 132(2). 177–195. 32 indexed citations

16.

Suckling, Keith E., William Kerns, Andrew Gee, et al.. (1994). SK&F 99085/SR-9223i, a novel hypocholesterolemic agent with multiple anti-atherosclerotic properties, lowers plasma cholesterol in normocholesterolemic animals. Atherosclerosis. 109(1-2). 166–167. 2 indexed citations

17.

Poller, L., Peter K. MacCallum, J M Thomson, & William Kerns. (1990). Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.. Heart. 63(4). 231–233. 23 indexed citations

18.

Consigny, P. Macke, George P. Teitelbaum, Geoffrey A. Gardiner, & William Kerns. (1989). Effects of laser thermal angioplasty on arterial contractions and mechanics. CardioVascular and Interventional Radiology. 12(2). 83–87. 9 indexed citations

19.

Staples, Robert, B. A. Burgess, & William Kerns. (1984). The Embryo–Fetal Toxicity and Teratogenic Potential of Ammonium Perfluorooctanoate (APFO) in the Rat. Toxicological Sciences. 4(3part1). 429–440. 1 indexed citations

20.

Swenberg, James A., et al.. (1980). Carcinogenicity of formaldehyde vapor: interim findings in a long-term bioassay of rats and mice.. PubMed. 8. 283–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact